Among the breast cancer cell lines used in the present study MCF7 exhibited high expression values and had an amplified CHRNA5 locus while the expression of BT20 was higher than that of MDA-MB-231 based on the CCLE dataset (Fig 1A). This evidence concerns the gene CHRNA5 and breast carcinoma.